Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

Lilly closes on US approval of lung cancer drug necitumumab

Lilly closes on US approval of lung cancer drug necitumumab Other drugs targeting EGFR are already on the market for NSCLC, including orally-active therapies such as Roche's Tarceva (erlotinib), AstraZeneca's Iressa (gefitinib) and Boehringer Ingelheim's Giotrif (afatinib). ... Boehringer has just reported phase

Boehringer plans new filings for Giotrif in lung cancer

Boehringer plans new filings for Giotrif in lung cancer The German pharma company reports that Giotrif (afatinib) was more effective than Roche's Tarceva (erlotinib) in extending the lives of previously treated SCC patients in the study, which has just ... In addition to Tarceva it also competes with Iressa

Opdivo approved via UK’s early drug access scheme

Opdivo approved via UK’s early drug access scheme Alimta (pemetrexed), and Roche's Tarceva (erlotinib) – all of which have seen positive NICE recommendations. .

NICE U-Turn on Boehringer oncology drug

NICE U-Turn on Boehringer oncology drug There are a number of NICE-approved medicines for NSCLC, including AstraZeneca's Iressa (gefitinib) and Roche's Tarceva (erlotinib), which are both targeted EGFR mutation positive treatments. .

Express Scripts pushes for pay-for-performance in cancer

Express Scripts pushes for pay-for-performance in cancer He gives the example of Roche and Astellas' Tarceva (erlotinib), which is less effective in pancreatic cancer than in lung cancer.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics